213 related articles for article (PubMed ID: 31373862)
1. Cross-Linked Hyaluronic Acid as Tear Film Substitute.
Posarelli C; Passani A; Del Re M; Fogli S; Toro MD; Ferreras A; Figus M
J Ocul Pharmacol Ther; 2019 Sep; 35(7):381-387. PubMed ID: 31373862
[No Abstract] [Full Text] [Related]
2. The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model.
Guarise C; Acquasaliente L; Pasut G; Pavan M; Soato M; Garofolin G; Beninatto R; Giacomel E; Sartori E; Galesso D
J Mech Behav Biomed Mater; 2023 Jul; 143():105908. PubMed ID: 37209594
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
5. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
Mencucci R; Boccalini C; Caputo R; Favuzza E
J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye.
Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R
Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755
[TBL] [Abstract][Full Text] [Related]
7. Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations.
Nakamura S; Okada S; Umeda Y; Saito F
Cornea; 2004 May; 23(4):390-7. PubMed ID: 15097136
[TBL] [Abstract][Full Text] [Related]
8. Protecting Tear-Film Stability under Adverse Environmental Conditions Using a Mucomimetic with a Non-Newtonian Viscosity Agent.
Abusharha A; Pearce EI; Afsar T; Razak S
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893580
[No Abstract] [Full Text] [Related]
9. Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial.
Laihia J; Järvinen R; Wylęgała E; Kaarniranta K
Acta Ophthalmol; 2020 May; 98(3):244-254. PubMed ID: 31579987
[TBL] [Abstract][Full Text] [Related]
10. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
Srinivasan S; Garofalo R; Williams R
Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model.
She Y; Li J; Xiao B; Lu H; Liu H; Simmons PA; Vehige JG; Chen W
J Ocul Pharmacol Ther; 2015 Nov; 31(9):525-30. PubMed ID: 26322539
[TBL] [Abstract][Full Text] [Related]
12. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease.
Schmidl D; Schmetterer L; Witkowska KJ; Unterhuber A; dos Santos VA; Kaya S; Nepp J; Baar C; Rosner P; Werkmeister RM; Garhofer G
Cornea; 2015 Apr; 34(4):421-6. PubMed ID: 25651494
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].
Vandermeer G; Chamy Y; Pisella PJ
J Fr Ophtalmol; 2018 Mar; 41(3):238-245. PubMed ID: 29573863
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome.
Tseng CL; Hung YJ; Chen ZY; Fang HW; Chen KH
PLoS One; 2016; 11(6):e0157982. PubMed ID: 27336157
[TBL] [Abstract][Full Text] [Related]
15. A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review.
Hynnekleiv L; Magno M; Moschowits E; Tønseth KA; Vehof J; Utheim TP
Acta Ophthalmol; 2024 Feb; 102(1):25-37. PubMed ID: 37042308
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye.
You IC; Li Y; Jin R; Ahn M; Choi W; Yoon KC
J Ocul Pharmacol Ther; 2018 Oct; 34(8):557-564. PubMed ID: 30036099
[TBL] [Abstract][Full Text] [Related]
17. A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome.
Yang YJ; Lee WY; Kim YJ; Hong YP
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33804439
[TBL] [Abstract][Full Text] [Related]
18. Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study.
Vandermeer G; Chamy Y; Pisella PJ
J Fr Ophtalmol; 2018 Feb; 41(2):e51-e57. PubMed ID: 29366588
[TBL] [Abstract][Full Text] [Related]
19. Effects of Menthol-Containing Artificial Tears on Tear Stimulation and Ocular Surface Integrity in Normal and Dry Eye Rat Models.
Ahn S; Eom Y; Kang B; Park J; Lee HK; Kim HM; Song JS
Curr Eye Res; 2018 May; 43(5):580-587. PubMed ID: 29419317
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye.
Postorino EI; Rania L; Aragona E; Mannucci C; Alibrandi A; Calapai G; Puzzolo D; Aragona P
Eur J Ophthalmol; 2018 Jan; 28(1):25-31. PubMed ID: 28777385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
